Elixinol Global Company Top Insiders
| ELLXF Stock | USD 0.01 0 145.45% |
Elixinol Global employs about 17 people. The company is managed by 7 executives with a total tenure of roughly 7 years, averaging almost 1.0 years of service per executive, having 2.43 employees per reported executive. Examination of Elixinol Global's management performance can provide insight into the company performance.
| Kim BradleyWare Executive Joint Company Secretary |
| Glen Zurcher Insider Account Department |
Elixinol |
Elixinol Global Management Team Effectiveness
The company has return on total asset (ROA) of (0.3266) % which means that it has lost $0.3266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7075) %, meaning that it generated substantial loss on money invested by shareholders. Elixinol Global's management efficiency ratios could be used to measure how well Elixinol Global manages its routine affairs as well as how well it operates its assets and liabilities.Elixinol Global holds a total of 316.27 Million outstanding shares. Elixinol Global shows 15.67 percent of its outstanding shares held by insiders and 4.83 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Elixinol Global in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Elixinol Global, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Elixinol Global Workforce Comparison
Elixinol Global is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 279. Elixinol Global holds roughly 17.0 in number of employees claiming about 6% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (1.72) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.63. Elixinol Global Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Elixinol Global Price Series Summation is a cross summation of Elixinol Global price series and its benchmark/peer.
Elixinol Global Notable Stakeholders
An Elixinol Global stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Elixinol Global often face trade-offs trying to please all of them. Elixinol Global's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Elixinol Global's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kim BradleyWare | Joint Company Secretary | Profile | |
| Glen Zurcher | Account Department | Profile | |
| FCPA BEC | Interim Officer | Profile | |
| Teresa Cleary | G Sec | Profile | |
| Rob Hasselman | Pres Americas | Profile | |
| Josephine Lorenz | Global Controller | Profile | |
| Beata Silber | Global Innovation | Profile |
About Elixinol Global Management Performance
The success or failure of an entity such as Elixinol Global often depends on how effective the management is. Elixinol Global management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Elixinol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Elixinol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. Elixinol Wellness operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Elixinol Global Workforce Analysis
Traditionally, organizations such as Elixinol Global use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Elixinol Global within its industry.Elixinol Global Manpower Efficiency
Return on Elixinol Global Manpower
| Revenue Per Employee | 831.1K | |
| Revenue Per Executive | 2M | |
| Net Loss Per Employee | 1M | |
| Net Loss Per Executive | 2.4M |
Complementary Tools for Elixinol Pink Sheet analysis
When running Elixinol Global's price analysis, check to measure Elixinol Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Global is operating at the current time. Most of Elixinol Global's value examination focuses on studying past and present price action to predict the probability of Elixinol Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Global's price. Additionally, you may evaluate how the addition of Elixinol Global to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |